In this review:
Factors on decisions to adjust therapy for RA
Descending modulation of pain
Reduced-dose etanercept plus methotrexate in early RA
Ustekinumab in active PsA
Abatacept vs. adalimumab on methotrexate background in RA
Clinical relevance
Please login below to download this issue (PDF)